Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Look: Discussing the recently released data from the Phase 3 OASIS-HAE clinical trial of donidalorsen in patients with Hereditary Angioedema

Ticker(s): IONS

Who's the expert?

Institution: The Doctors Clinic

Board certified is Allergy-Immunology and Internal Medicine
sees adult and pediatric patients for a wide range of allergic and immmunologic conditions.
treats 8-10 patients annually for HAE and has prescribed Haegarda, Orladeyo, and Takhzyro

Interview Goal

to discuss the current standard of care and the potential of donidalorsen, an investigative prophylactic medicine being developed by Ionis Pharma to prevent HAE attacks.

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.